Clincosm LogoSign in Get a demo

Descriptive Study of the Incidence and Outcome of PAS in Two Large Referral Hospitals in Egypt

Sponsor
Cairo University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05636865
Collaborator
(none)
10,000
Enrollment
1
Location
8
Anticipated Duration (Months)
1252.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

placenta accreta spectrum incidence and outcome

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    placenta accreta spectrum ( PAS ) one of the most serious condition in obstetrics nowadays so the investigators measure the incidence by this study

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    10000 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Descriptive Study of the Incidence and Outcome of PAS in Two Large Referral Hospitals in Egypt , Kasr Alainy Hospital , Cairo University , and Banisuef Specialized Hospital in Last 6 Years
    Actual Study Start Date :
    Jul 30, 2022
    Actual Primary Completion Date :
    Nov 10, 2022
    Anticipated Study Completion Date :
    Mar 30, 2023

    Outcome Measures

    Primary Outcome Measures

    1. number of diagnosed pregnant women with placenta accreta spectrum [in last 6 years]

      pregnant women with gestitional age above 18 week , with confirmed diagnosis with PAS with U/S

    Secondary Outcome Measures

    1. incidence of hystrectomy [in last 6 years]

      hystrectomy VS conservative management

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    Female
    Inclusion Criteria:
    • gestational age above 28 weeks
    Exclusion Criteria:
    • age less than 18

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kasr Alainy , Cairo University Cairo Egypt 002

    Sponsors and Collaborators

    • Cairo University

    Investigators

    • Principal Investigator: rihab hagag, resident, kasr alainy

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Rihab Hagag Sayed, resident doctor , principle investigator, Cairo University
    ClinicalTrials.gov Identifier:
    NCT05636865
    Other Study ID Numbers:
    • MS-26-2022
    First Posted:
    Dec 5, 2022
    Last Update Posted:
    Dec 5, 2022
    Last Verified:
    Nov 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Rihab Hagag Sayed, resident doctor , principle investigator, Cairo University
    PAS
    Additional relevant MeSH terms:
    Placenta Accreta

    Study Results

    No Results Posted as of Dec 5, 2022